Highlights included a 32.2% year in year increase in total revenue to a record high of $100.8 million. And with net profits ...

One of two of Opthea's phase III trials for a common eye disease has failed to meet its objectives, casting doubts on the ...

Bioxyne's latest capital raise has proved fruitful, filling the company's coffers ahead of its push into European markets. ..

Investors are bidding up the Mineral Resources share price on Monday. Is this why? The post Why is the Mineral Resources share price racing ahead of the ASX 200 on Monday? appeared first on The Motley ...

Shares fall as Trump spurs caution; MinRes resumes Onslow haulage; sell-off hits James Hardie; Helia plummets as CBA courts ...

S&P/ASX 200 Index (ASX: XJO) gold stocks have rocketed higher in 2025. Here’s why April could be another banner month for the ...

A recap of the most heavily shorted stocks on the ASX and those experiencing significant changes to short interest over the ...

With the Australian Government set to hand down its budget tomorrow (25 March), investors are starting the week largely on ...

As the sun rises over the Australian market, traders should brace themselves for a potentially rocky day with ASX 200 futures down 41 points (-0.51%) as of 8:30 AM AEDT. In this morning wrap, we will ...

The mixed performance of these tech giants illustrates the volatility present in the tech sector, which has a dictating influence on overall market trends. Investors are particularly wary as ...

Welcome back to the 52-Week Series, where we recap the S&P/ASX 200 stocks that have hit fresh yearly highs and lows over the ...